Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Kalpadakis

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Haematologica|February 22, 2008
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomibKonstantinos Anargyrou, Evangelos Terpos, Theodoros P Vassilakopoulos, et al.
Current Topics in Medicinal Chemistry|October 5, 2006
Immunotherapeutic and immunoregulatory drugs in haematologic malignanciesGerassimos A Pangalis, Marie-Christine Kyrtsonis, Theodoros P Vassilakopoulos, et al.
Biomed Research International|August 28, 2014
Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemiaMarie-Christine Kyrtsonis, Katerina Sarris, Efstathios Koulieris, et al.
Anticancer Research|May 17, 2019
Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical TrialsSotirios Sachanas, Gerassimos A Pangalis, Anna-Maria Fink, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL)Marie-Christine Kyrtsonis, Georgia Levidou, Penelope Korkolopoulou, et al.
Leukemia & Lymphoma|December 8, 2010
Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimenSotirios Sachanas, Gerassimos A Pangalis, Theodoros P Vassilakopoulos, et al.
Anticancer Research|December 13, 2005
Serum levels of soluble syndecan-1 in Hodgkin's lymphomaTheodoros P Vassilakopoulos, Marie-Christine Kyrtsonis, Argiroula Papadogiannis, et al.
Leukemia & Lymphoma|May 24, 2013
Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemiaSotirios Sachanas, Georgia Levidou, Maria K Angelopoulou, et al.
British Journal of Haematology|April 6, 2007
Prognostic value of serum free light chain ratio at diagnosis in multiple myelomaMarie-Christine Kyrtsonis, Theodoros P Vassilakopoulos, Nicoletta Kafasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphomaIpatia A Doussis-Anagnostopoulou, Theodoros P Vassilakopoulos, Irini Thymara, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Haematologica|February 22, 2008
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomibKonstantinos Anargyrou, Evangelos Terpos, Theodoros P Vassilakopoulos, et al.
Current Topics in Medicinal Chemistry|October 5, 2006
Immunotherapeutic and immunoregulatory drugs in haematologic malignanciesGerassimos A Pangalis, Marie-Christine Kyrtsonis, Theodoros P Vassilakopoulos, et al.
Biomed Research International|August 28, 2014
Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemiaMarie-Christine Kyrtsonis, Katerina Sarris, Efstathios Koulieris, et al.
Anticancer Research|May 17, 2019
Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical TrialsSotirios Sachanas, Gerassimos A Pangalis, Anna-Maria Fink, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL)Marie-Christine Kyrtsonis, Georgia Levidou, Penelope Korkolopoulou, et al.
Leukemia & Lymphoma|December 8, 2010
Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimenSotirios Sachanas, Gerassimos A Pangalis, Theodoros P Vassilakopoulos, et al.
Anticancer Research|December 13, 2005
Serum levels of soluble syndecan-1 in Hodgkin's lymphomaTheodoros P Vassilakopoulos, Marie-Christine Kyrtsonis, Argiroula Papadogiannis, et al.
Leukemia & Lymphoma|May 24, 2013
Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemiaSotirios Sachanas, Georgia Levidou, Maria K Angelopoulou, et al.
British Journal of Haematology|April 6, 2007
Prognostic value of serum free light chain ratio at diagnosis in multiple myelomaMarie-Christine Kyrtsonis, Theodoros P Vassilakopoulos, Nicoletta Kafasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphomaIpatia A Doussis-Anagnostopoulou, Theodoros P Vassilakopoulos, Irini Thymara, et al.
Pageof 6